This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Clinical Data Disclosure & Transparency
September 10-11, 2026
The Logan Hotel, Philadelphia, PA

Stephen Lam
Business Manager (Clinical Investigations and Trials) at Medicines and Healthcare products Regulatory Agency (MHRA)
Speaker

Profile

Stephen Lam is the Business Manager in the Clinical Investigations & Trials Operations team at the Medicines and Healthcare products Regulatory Agency (MHRA). He has over eleven years of experience at the MHRA, including eight years in Clinical Trials. Stephen led the coordination and management of the Combined Ways of Working (CWoW) pilot at the MHRA, now formally known as the Combined Review process. He contributed significantly to drafting the new UK Clinical Trials Regulation and is currently focused on its implementation ahead of April 2026. His work spans regulatory operations, stakeholder engagement, and strategic delivery.

Agenda Sessions

  • MHRA and HRA Update – UK Transparency Procedures

    10:45am